The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns

Hein D, Dreisig K, Metzler M, Izraeli S, Schmiegelow K, Borkhardt A, Fischer U (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Blood American Society of Hematology

Book Volume: 134

Pages Range: 1355-1358

Journal Issue: 16

DOI: 10.1182/blood.2019002215

Authors with CRIS profile

Markus Metzler Professur für Kinder- und Jugendmedizin mit dem Schwerpunkt Pädiatrische Onkologie und Hämatologie

Involved external institutions

Schneider Children's Medical Center IL Israel (IL) Universitätsklinikum Düsseldorf DE Germany (DE) Rigshospitalet DK Denmark (DK)

How to cite

APA:

Hein, D., Dreisig, K., Metzler, M., Izraeli, S., Schmiegelow, K., Borkhardt, A., & Fischer, U. (2019). The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns. Blood, 134(16), 1355-1358. https://doi.org/10.1182/blood.2019002215

MLA:

Hein, Daniel, et al. "The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns." Blood 134.16 (2019): 1355-1358.

BibTeX: Download